Toru Satoh Selected Research

Pulmonary Arterial Hypertension

11/2023	Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension.
9/2022	Reversible Cardiac Hypertrophy in Pulmonary Arterial Hypertension Treated With High-Dose Epoprostenol.
1/2022	Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmonary arterial hypertension.
1/2022	Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension.
1/2021	Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases.
3/2020	Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension　- Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers.
1/2020	Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
5/2019	Safety and Efficacy of Ambrisentan-Phosphodiesterase Type 5 (PDE5) Inhibitor Combination Therapy for Japanese Pulmonary Arterial Hypertension Patients in Real-World Clinical Practice.
1/2019	Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.
1/2018	Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toru Satoh Research Topics

Disease

33	Pulmonary Arterial Hypertension 11/2023 - 02/2007
31	Pulmonary Hypertension 11/2023 - 03/2005
14	Heart Failure 01/2019 - 09/2002
7	Myocardial Infarction 01/2018 - 05/2002
6	Connective Tissue Diseases (Connective Tissue Disease) 11/2023 - 01/2010
6	Familial Primary Pulmonary Hypertension 09/2022 - 03/2002
4	Trigeminal Neuralgia (Tic Douloureux) 09/2023 - 01/2007
4	Hypertrophy 09/2022 - 01/2012
4	Pulmonary Edema 09/2016 - 01/2011
3	Dyspnea (Shortness of Breath) 09/2022 - 03/2004
3	Hemifacial Spasm 01/2022 - 08/2006
3	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 12/2013
2	Intracranial Aneurysm (Cerebral Aneurysm) 04/2024 - 10/2002
2	Ascites 11/2023 - 12/2013
2	Heart Diseases (Heart Disease) 01/2023 - 01/2016
2	Aortic Dissection 01/2022 - 06/2005
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2019
2	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2017 - 01/2012
2	Ventricular Remodeling 01/2017 - 04/2003
2	Hypertension (High Blood Pressure) 01/2017 - 10/2015
2	Left Ventricular Dysfunction 01/2017 - 10/2012
2	Infections 08/2014 - 01/2013
2	Hypoxia (Hypoxemia) 01/2013 - 01/2012
2	Inflammation (Inflammations) 01/2012 - 01/2010
2	Multiple Myeloma 03/2005 - 09/2004
2	Heart Rupture 04/2003 - 01/2003
2	Infarction (Infarctions) 02/2003 - 01/2003
1	High Cardiac Output 11/2023
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Polycythemia Vera 01/2023
1	Cardiomegaly (Heart Hypertrophy) 09/2022
1	Emphysema 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Right Ventricular Hypertrophy 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Chronic Renal Insufficiency 01/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2018
1	Gastritis 01/2018
1	Neoplasms (Cancer) 07/2017
1	Hemorrhage 07/2017
1	Breast Neoplasms (Breast Cancer) 07/2017
1	Cardiomyopathies (Cardiomyopathy) 07/2017
1	Vascular Remodeling 01/2017
1	Vitamin D Deficiency 01/2017
1	Vascular System Injuries 09/2016
1	Syncope (Fainting) 07/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016
1	Cardiac Arrhythmias (Arrythmia) 07/2016

Drug/Important Bio-Agent (IBA)

20	Epoprostenol (Prostacyclin)FDA LinkGeneric 11/2023 - 12/2003
6	C-Reactive ProteinIBA 01/2019 - 01/2003
6	Sildenafil Citrate (Viagra)FDA Link 09/2012 - 10/2004
5	Oxygen (Dioxygen)IBA 01/2022 - 10/2002
5	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 08/2016 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2004
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 08/2004
4	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 02/2016 - 12/2013
3	selexipagIBA 01/2022 - 08/2017
3	Phosphodiesterase 5 InhibitorsIBA 01/2021 - 05/2015
3	Vasodilator Agents (Vasodilators)IBA 01/2017 - 01/2014
3	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2012
3	CytokinesIBA 01/2010 - 09/2002
3	Carvedilol (Coreg)FDA LinkGeneric 03/2008 - 10/2003
3	Metoprolol (Toprol-XL)FDA LinkGeneric 03/2008 - 10/2003
2	treprostinil FDA Link 11/2023 - 09/2022
2	ProstaglandinsIBA 09/2022 - 01/2022
2	Therapeutic UsesIBA 01/2021 - 05/2003
2	MonocrotalineIBA 01/2021 - 12/2005
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 10/2012
2	Tolvaptan FDA Link 01/2016 - 07/2015
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015 - 10/2012
2	Carbon MonoxideIBA 10/2014 - 12/2013
2	Bosentan (Tracleer)FDA Link 01/2012 - 02/2007
2	Radioisotopes (Radionuclides)IBA 10/2005 - 10/2003
1	MetalsIBA 04/2024
1	Clostridium perfringens epsilon-toxinIBA 01/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023
1	monocrotaline pyrroleIBA 01/2021
1	ambrisentan FDA Link 05/2019
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2019
1	DiureticsIBA 01/2019
1	BariumIBA 01/2018
1	IronIBA 01/2018
1	Epoprostenol ReceptorsIBA 08/2017
1	AnthracyclinesIBA 07/2017
1	Trastuzumab (Herceptin)FDA Link 07/2017
1	hydroxide ionIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	riociguatIBA 01/2016

Therapy/Procedure

31	Therapeutics 01/2023 - 09/2002
6	Microvascular Decompression Surgery 09/2023 - 08/2006
6	Endarterectomy (Thromboendarterectomy) 07/2018 - 01/2014
3	Catheters 01/2019 - 08/2014
2	Stents 04/2024 - 01/2022
2	Intravenous Infusions 01/2015 - 01/2013
1	Drug Therapy (Chemotherapy) 07/2017
1	Thrombectomy 07/2017
1	Cardiopulmonary Resuscitation (CPR) 07/2016
1	Defibrillators (Defibrillator) 07/2016
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2016